fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Center for EDS Opens at Sheba

Center for EDS at Sheba Medical Center in Israel
The dedicated facility offers diagnosis, treatment, rehabilitation and research for Ehlers-Danlos syndromes, a group of rare inherited conditions that affect connective tissue.

Ehlers-Danlos Syndrome (EDS) causes damage to the body’s connective tissue structure, which includes skin, tendons, ligaments, blood vessels, bones, and internal organs. A gene mutation causes connective tissue (the specific kind depends on the type of EDS) to be stretchy and fragile. Sometimes, the stretchiness is visible in the skin of a person with EDS, while other people have hypermobility – they can extend their joints further than usual. The symptoms of EDS are broad and can be complex, affecting many body systems simultaneously and including intense long-term pain, chronic fatigue, digestive disorders, and palpitations.

In Israel, there are approximately 500 patients with EDS; about 87% are women. Unfortunately, due to a lack of awareness of the disease, many of these people have not received the necessary treatments

Dr. Yael Gazit, pediatrician and EDS specialist, heads the new Center for Diagnosis and Treatment of Ehlers-Danlos Syndromes. She shared, “We have begun to collaborate with the hospital’s multidisciplinary teams to build a broad therapeutic and rehabilitative program for patients with EDS. Already, we are witnessing an increase in the number of patients who approach us and receive a response after many years of being undiagnosed or untreated.”

Center for EDS ( Ehlers-Danlos Syndrome) opens at Sheba

“As a part of the public health movement in Israel, Sheba will lead the treatment of patients with EDS. Our emphasis is on continuity of care, including diagnosis, treatment, rehabilitation, and research. We are devoting special resources and attention to the population of EDS patients,” said Prof. Gabriel Zeilig, Director of Neurological Rehabilitation Division at Sheba.

“I’m happy for this opportunity to coordinate the care of EDS patients under one roof, giving them an optimal overall medical response,” adds Gazit.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More